GlaxoSmithKline profits grow 13%

The growing demand for drugs to fight diabetes and depression has helped the newly merged pharmaceutical company GlaxoSmithkline get off to a strong start.

Pre-tax profits have risen 13% to £5.3 billion from £4.7 billion while pharmaceutical sales grew by 10% to £15.43 billion.